Malignant mesothelioma is a form of cancer that is highly resistant to conventional cancer therapy for which no major therapeutic advances have been introduced. Here, we identify gremlin-1, a known bone morphogenetic protein inhibitor crucial for embryonic development, as a potential therapeutic target for mesothelioma. We found high expression levels of gremlin-1 in the mesothelioma tumor tissue, as well as in primary mesothelioma cells cultured from pleural effusion samples. Downregulation of gremlin-1 expression by siRNA-mediated silencing in a mesothelioma cell line inhibited cell proliferation. This was associated with downregulation of the transcription factor slug as well as mesenchymal proteins linked to cancer epithelial-to-mesenchymal transition. Further, resistance to paclitaxel-induced cell death was associated with high gremlin-1 and slug expression. Treatment of gremlin-1-silenced mesothelioma cells with paclitaxel or pemetrexed resulted in efficient loss of cell survival. Finally, our data suggest that concomitant upregulation of fibrillin-2 in mesothelioma provides a mechanism for extracellular localization of gremlin-1 to the tumor microenvironment. This was supported by the demonstration of interactions between gremlin-1, and fibrillin-1 and -2 peptides as well as by colocalization of gremlin-1 to fibrillin microfibrils in cells and tumor tissue samples. Our data suggest that gremlin-1 is also a potential target for overcoming drug resistance in mesothelioma.
INTRODUCTION
Malignant mesothelioma is an aggressive tumor, which originates from the mesothelial surface cells lining the serous body cavities such as the pleura, peritoneum or pericardium. 1 Mesothelioma is strongly linked to asbestos exposure, and it may take several decades to develop after initial exposure. 2 Because of the long latency, the incidence of mesothelioma will increase in the near future worldwide. 3, 4 Mesothelioma is resistant to chemo-and radiotherapy, leading to poor prognosis for patients suffering from this malignancy. 4 New markers for screening and monitoring the disease and in particular new drug targets are needed.
Cancer progression is associated with a re-expression of developmental programs, which contribute to the proliferative and invasive properties of tumor cells. 5, 6 Gremlin-1 is a cysteine knot protein, which belongs to the DAN family of bone morphogenetic protein (BMP) antagonists. Gremlin-1 can bind to and inhibit the functions of BMP-2, -4 and -7. 7, 8 These three BMP isoforms are targeted to fibrillin microfibrils, suggesting extracellular regulation of bioavailability. 9 Gremlin-1-mediated BMP antagonism is crucial for mouse lung and kidney development. 10 In adult mouse and human tissues gremlin-1 expression is low. Originally, gremlin-1 was identified as a gene downregulated in v-mos-transformed fibroblasts and therefore called Drm. 11 However, recent studies suggest the overexpression of gremlin-1 in epithelial cancers including lung carcinomas. 12, 13 The role of gremlin-1 in cancer has remained largely unclear. As our preliminary results suggested an upregulation of gremlin in mesothelioma tissue, we set out to find molecular interactions of gremlin and study the biological function of gremlin in mesothelioma.
RESULTS

Gremlin-1 interacts with fibrillin-1 and -2
A search for new gremlin interacting proteins was carried out using systematic affinity purification coupled with mass spectrometry identification (AP-MS). We used the well-characterized FlipIn-HEK293 cell system to produce C-terminally tagged gremlin-1 and a standardized workflow for the purification of protein complexes from cell lysates 14 ( Figure 1a) . A low tetracycline concentration (25 ng/ml) was selected for gremlin-1 induction (Figure 1b) . Immunoblotting analyses after different affinity purification steps suggested that gremlin was well recovered (Figure 1c) .
In order to characterize the interactome of gremlin-1, immunopurified proteins were identified using mass spectrometry. Proteins were first digested using trypsin and then fractionated with reverse-phase chromatography online using a mass spectrometer. The resulting peptide spectra were identified with two different search engines. A total of 12 proteins were identified to interact with gremlin-1 in three replicate experiments and with both search engines. The interaction data were filtered using a protein list (data not shown) of 377 unspecific binding proteins acquired using Flip-In-HEK293 cell line transfected with the affinity tag containing plasmid. The final filtered list contained four proteins: cytokeratin-9 (Swiss-Prot: P35527), fibrillin-2 (SwissProt: P35556), cytokeratin-2a (Swiss-Prot: P35908) and APOBEC1-binding protein 2 (Swiss-Prot: Q9UBS4). Fibrillin-2 was identified in all three replicate experiments and with both search engines, which improves the confidence of the identification. In addition, fibrillin-2 was identified with up to three distinct and good scoring peptides in two of the replicates further validating the interaction of fibrillin-2 and gremlin-1. Fibrillins are constituents of extracellular microfibrils and have a role in elastin assembly. 15 They also sequester and regulate the bioavailability of growth factors such as BMP isoforms. 9 In order to confirm our findings, we tested direct interactions between purified gremlin-1 and recombinant N-terminal peptides of fibrillin-1 and -2 in protein-protein interaction assays using surface plasmon resonance technology. When purified gremlin-1 ( Figure 1d ) was used as a ligand immobilized on the sensor chip surface and N-terminal fibrillin were flown over as analytes direct interactions with molecular affinities in the low nanomolar range (Table 1 ) could be measured (Figure 1e ). This suggests a high loaded HiTrap column using a C-terminally placed His 6 -affinity-tag protein, bands corresponding to monomeric, dimeric and multimeric gremlin-1 were detected via SDS-PAGE followed by Coomassie staining. A subsequent second purification step via a HiTrap heparin column yielded mostly dimeric gremlin-1, which shifted to the position of monomeric gremlin under reducing conditions ( þ SH). (e) Interaction studies between gremlin-1 and N-terminal peptides of fibrillin-1 and -2 using a surface plasmon resonance technology. Gremlin-1 was immobilized on a sensor chip and fibrillin-1 and -2 peptides in a concentration range from 80 to 0 nM were flown over as analytes. Affinity constants (K d ) for both interactions were about 10 nM (Table 1) , indicating a high affinity interaction between gremlin-1 and the main building blocks of fibrillin microfibrils. 
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Gremlin-1 and fibrillin-2 are overexpressed in the mesothelioma tumor tissue and colocalize in vivo To analyze whether gremlin-1 and fibrillins are coexpressed in vivo, tissue biopsies from mesothelioma patients included in this study were stained with specific antibodies. We had previously shown low levels of gremlin expression in the normal lung. 16 Here, we detected low expression of gremlin in normal mesothelial cells (Figure 2a ). Gremlin-1 staining was, however, detected in non-malignant, reactive mesothelial cells in control samples (pneumothorax). Intense gremlin-1 immunoreactivity was observed in all mesothelioma samples (n ¼ 6). Fibrillin-2 immunoreactivity was shown in a strikingly similar staining pattern as observed for gremlin-1 in these tumor samples, suggesting concomitant upregulation of these developmental genes in mesothelioma. Some fibrillin-2 staining was detectable also in non-malignant reactive mesothelium. Calretinin and WT1 (Wilm's tumor 1) are diagnostic markers for mesothelioma and were used here to identify the tumor tissue. Analyses of serial tissue sections suggested that gremlin-1 and fibrillin-2 staining localizes to calretinin-positive and -negative tumor areas (Figure 2b ). Some WT-1 positivity, however, was observed in calretinin-negative areas, which represent sarcomatoid part of the tumor with more diffuse growth properties. Fibrillin-1 staining was negative in 5/6 mesothelioma and in control pleura samples. Only one mesothelioma sample showed fibrillin-1 immunoreactivity, which was specifically detected in stromal-like areas (not shown).
We analyzed colocalization of gremlin-1 with fibrillin-2 in tumor tissue using the proximity ligation assay. Intensive colocalization signals were observed for gremlin-1 and fibrillin-2 throughout the tumor tissues, suggesting that they localize to similar structures in vivo (Figure 3 ).
Primary human mesothelioma cells express high levels of gremlin-1 and fibrillin-2 Primary cells were cultured from mesothelioma patients' pleural effusion samples (JP1-5). Cells were characterized by immunofluorescence staining using mesothelial markers calretinin and cytokeratin (CK)-7 as well as vimentin, which is commonly expressed by tumor cells. Majority of the cells were calretininand/or CK-7 positive and stained also for vimentin (Figure 4a ). This suggests that the cells, which were able to proliferate, were mainly primary tumor cells. Gremlin-1 mRNA expression levels were high in these primary cells compared with Met5A cells, which are immortalized but non-tumorigenic mesothelial cells (Figure 4b) . Further, the mRNA expression levels of fibrillin-1 and -2 were high in these cells (Figure 4b ). The results show that primary mesothelioma cells can be cultured from pleural effusion samples and that the cells retain the phenotypic expression of these developmental genes.
Gremlin-1 is known to inhibit the functions of BMP-2, -4 and to some extent also BMP-7. 7, 8 Therefore, the expression levels of these BMP isoforms were analyzed in primary mesothelioma cells. Interestingly, abundant expression of BMP-2 was observed (Figure 4b ), whereas BMP-4 levels were comparable and BMP-7 levels only slightly higher compared with Met5A cells (not shown).
The expression patterns of gremlin-1, fibrillins and BMP-2 were also analyzed in four established mesothelioma cell lines (211H, H28, H2452 and H2052). Only one of these cell lines, H2052, resembled primary mesothelioma cells and expressed high levels of gremlin-1, fibrillin-2 and BMP-2 ( Figure 4c) . Therefore, this cell line was chosen for further mechanistic studies.
Gremlin-1 associates with fibrillin-1 in cultured mesothelioma cells Mesothelioma cells were cultured for 1 week and then analyzed by immunofluorescence staining using antibodies specific for gremlin-1 or fibrillins. Although expressed at the mRNA level, fibrillin-2 protein was not detected in any of the cultured mesothelioma cells analyzed at this time point (not shown), which may reflect late extracellular matrix (ECM) deposition in vitro. Primary mesothelioma cells and H2052 cells in vitro also expressed fibrillin-1 mRNA, and this was reflected in the staining pattern showing fibrillar staining for fibrillin-1 and gremlin-1 ( Figure 5a ). No staining was observed in H2452 cells. Double immunofluorescence labeling suggested colocalization and targeting of gremlin-1 into fibrillin-1 containing microfibrils in vitro. H2052 cells transfected with fibrillin-1-specific siRNA showed reduced mRNA expression levels ( Figure 5b ) and significantly reduced fibrillin-1 staining, indicating efficient silencing of protein expression ( Figure 5c ). This led to reduced deposition of gremlin into fibrillar structures suggesting that extracellular targeting of gremlin is dependent on fibrillins.
Gremlin-1 silencing severely impairs mesothelioma cell growth and survival To investigate the role of gremlin-1 in mesothelioma cell growth, H2052 cells were transfected with gremlin-specific siRNAs.
Efficient silencing of gremlin-1 expression was observed at mRNA and protein levels (Figures 6a and b) . Cell proliferation was assayed by counting cells 1-5 days after transfection. Two independent siRNAs targeted against gremlin-1 were observed to significantly decrease the number of cells at all time points (Figure 6c ). This suggests that H2052 cell proliferation is dependent on gremlin expression.
To determine whether lack of gremlin induces apoptosis, H2052 cells were cultured on coverslips, transfected with siRNAs and analyzed with TUNEL assay 3 days after transfection ( Figure 6d ). Hardly any TUNEL-positive cells were detected in control or gremlin siRNA-transfected cells. DAPI staining also showed intact nuclei in both groups. These results suggest that although lack of gremlin impaired cell proliferation, it did not induce apoptosis.
Cellular signaling pathway activities are altered in gremlin-1-silenced cells Changes in BMP signaling activity were analyzed. Gremlin-1 silencing increased BMP-dependent reporter activity in H2052 cells ( Figure 7a ) as well as the expression of a BMP target gene Id1 (inhibitor of differentiation/DNA binding 1, Figure 7b ), suggesting that endogenous gremlin-1 regulates BMP activity negatively. Further, Id1 expression was found significantly reduced in primary mesothelioma cells compared with Met5A cells (Figure 7c ).
To further investigate cellular signaling pathways regulated by gremlin, we analyzed alteration in phospho-kinase levels using a commercial array (see Materials and methods). H2052 cells were found to have high basal level of phospho-Akt (S473), which was not altered in gremlin-1-silenced cells (Figures 7d-f ). However, phosphorylation of the Akt substrate and regulator of mTOR signaling, PRAS40 (T246), was increased. Erk1/2 phosphorylation was also significantly increased in gremlin-1-silenced cells (g). Further, increased levels of p53 phosphorylation (S46 and S392) Gremlin-1 expression is associated with EMT phenotype and chemoresistance Gremlin-1 expression has been linked to EMT processes. Therefore, we determined whether mesothelioma cells with high gremlin levels express transcription factors snail and slug, which are transcriptional repressors of E-cadherin and induce EMT. 17 Whereas the mRNA expression levels of snail were comparable in mesothelioma cells and Met5A cells, slug expression levels were high in primary mesothelioma cells (Figure 8a ). Slug expression in mesothelioma tumor samples was analyzed using immunohistochemical staining (Figures 8b and c) . All of the analyzed tumor samples (n ¼ 6) were positive for slug. Mesothelioma tumors exhibited mostly diffuse and granular cytoplasmic staining, but also nuclear staining was detected in certain tumor areas. Slug staining localized to gremlin-positive areas and was detected also in calretinin-negative areas.
Similar to primary mesothelioma cells H2052 cells, which express high levels of gremlin-1, exhibited high slug expression (Figure 8d ). Conversely, Met5A and H2452 cells showed very low levels of slug mRNA expression consistent with low gremlin-1 expression levels. Slug protein levels also showed a dramatic difference between H2052 and H2452 cells (Figure 8d 8h and i). Fibrillin-1 and -2 mRNA expression levels were also significantly reduced (Figure 8h ), suggesting that gremlin-1 maintains the expression of microfibrillar genes. Further, fibronectin expression was downregulated (Figure 8h ), and the epithelial marker E-cadherin was upregulated (Figure 8j ). These results suggest that EMT-related alterations are reversed in gremlin-1-silenced cells.
Slug expression and EMT-phenotype are also associated with tumor chemoresistance. [18] [19] [20] [21] The importance of high gremlin and slug expression to sensitivity to paclitaxel-mediated mesothelioma cell death was analyzed using the MTT proliferation/viability assay. H2052 cells, which express high levels of gremlin-1 and slug, were found more resistant to paclitaxel than H2452 cells (Figure 8k ). Next, control and gremlin-1 siRNA-transfected H2052 cells were treated with paclitaxel or pemetrexed, and cell numbers were quantified 3 days after transfection. Treatment with paclitaxel or pemetrexed in combination with gremlin-1 siRNA led to efficient cell death (Figure 8l ).
DISCUSSION
Gremlin-1-mediated inhibition of BMP-signaling is important for normal development. Mice lacking gremlin-1 die before birth because of severe defects in kidney and lung development. 10 In Figure 5 . Gremlin-1 and fibrillin-1 co-localize in mesothelioma cell ECM in vitro. adult tissues including lung gremlin-1 expression is low. In idiopathic pulmonary fibrosis , gremlin-1 is highly upregulated in the lung parenchyma, where it contributes to idiopathic pulmonary fibrosis pathogenesis by blocking BMP-mediated signals. 16 Gremlin-1 has been found to be upregulated also in many carcinoma tissues as well as in mesothelioma. 12, 13, 22 The role of gremlin-1 in malignant tissue appears complex and is likely mediated both by BMP-dependent and -independent functions. There are reports suggesting tumor-specific gremlin-1 expression, 12 while other reports suggest expression in cancerassociated stromal cells. 13 Here, we find high gremlin immunoreactivity in the mesothelioma tumor tissue. Analyses of serial mesothelioma tissue sections suggested that gremlin-1 can localize to calretinin-positive, epithelial-appearing tumor areas and also to aberrant looking and stromal-like calretinin-negative areas. These tissue areas contained some WT1-positive tumor cells. Our results suggest that gremlin-1 localizes mainly in and around mesothelioma tumor cells.
Using a sophisticated large-scale protein interaction screen, we were able to identify fibrillin-2 as a novel gremlin-1 interacting protein. The interaction was also verified using a cell surface plasmon resonance technology. Fibrillin-2 is a developmental gene, which is found in adult vasculature and is upregulated in idiopathic pulmonary fibrosis, scleroderma and during skin wound healing. 23, 24 Idiopathic pulmonary fibrosis and cancer pathogenesis have common features including aberrant activation of mediators of tissue repair processes. 25 Our discovery that high fibrillin-2 immunoreactivity is associated with mesothelioma tumor tissue is a novel finding and supports this idea. Fibrillins (fibrillin-1 and -2) are large extracellular glycoproteins, which form heteromeric fibrillar structures, the so called fibrillin microfibrils, which are essential for elastin assembly. 26 Fibrillins also regulate growth factor signaling by sequestering TGF-b complexes as well as BMP-isoforms into extracellular matrix structures. 27 Gremlin-1 can bind to and inhibit the functions of BMP-2, -4 and -7, all of which have been shown to associate with fibrillins. 9 Here, we find that gremlin-1 can bind to fibrillin-1 and -2 in vitro and colocalizes with fibrillin-2 in mesothelioma tumor tissue in vivo. Conceptually this is a new finding, spatially localizing a BMP inhibitor molecule with its target proteins through fibrillin microfibrils. High levels of fibrillin-2 are likely to contribute to tumor cell behavior through aberrant extracellular matrix structure and regulation of gremlin-1 function. Primary mesothelioma cells were cultured from patients' pleural effusion samples and analyzed after few passages of culture. Immunofluorescence microscopy analyses indicated that the cells, which were able to grow, represented mostly tumor cells. Gremlin-1 was expressed at mRNA and protein levels and fibrillin-2 at mRNA level by these primary cells, suggesting that they retain the pathological expression pattern of these genes. Interestingly, fibrillin-1 but not fibrillin-2 protein was detected in the matrix structures after 1 week culture of the primary cells. This likely reflects the temporal production of ECM proteins and remodeling of matrix structures during in vitro cell cultures. 28, 29 Fibrillin-2 is likely assembled late during this process. In agreement with the protein interaction studies, gremlin-1 localized to fibrillin-1- containing structures in mesothelioma cell ECM. Gene expression analyses suggested that compared with immortalized but nontumorigenic mesothelial cells (Met5A), primary mesothelioma cells also expressed significantly higher levels of BMP-2. This is an interesting finding as BMP-2 has been linked to tumor invasion and metastasis. [30] [31] [32] Future studies will reveal whether BMP-2 is functional in the presence of high levels of its inhibitor protein.
We used the knowledge of gene expression patterns of primary mesothelioma cells to find a representative established mesothelioma cell line for mechanistic studies. H2052 cells expressed high levels of gremlin-1, fibrillin-2 and BMP-2 similar to all of the primary cells. Gremlin-1 silencing in these cells reduced cell proliferation dramatically. This is in agreement with previous studies suggesting that gremlin-1 can induce proliferation of cancer cells. [33] [34] [35] Interestingly, we observed gremlin-1 immunoreactivity also in reactive mesothelium, which associates gremlin-1 expression to a proliferative phenotype even in nonmalignant mesothelial cells. Gremlin-1 expression has been linked to mesenchymal cells surrounding stem cell niches, which support proliferation of epithelial cells through blocking BMP activities. 13, 36 Mesenchymal stem cells also express high levels of gremlin-1 (GeneSapiens database 37 ). Our data suggest a model in which cancer cells can acquire the ability to produce high levels of gremlin-1, which is targeted to the tumor microenvironment through fibrillin binding (see Figure 9) .
Signaling pathways linked to the regulation of cell survival, apoptosis and autophagy were altered in gremlin-1-silenced H2052 cells. Similar to our findings, negative regulation of Erk1/2 phosphorylation by gremlin-1 has been previously found in osteosarcoma cells; 38 however, gremlin overexpression in Saos-2 cell was found to reduce proliferation. We observed increased p53 phosphorylation and expression of its target gene, p21, in gremlin-1-silenced cells, suggesting a link to reduced cell survival. Further, the phosphorylation of the Akt substrate PRAS40 was significantly increased. Although PRAS40 has been linked to diabetes and cancer, its pathological functions are not well understood. 39 Interestingly, gremlin-1 has been shown to bind directly to a 14-3-3 protein, 12 which in turn binds and regulates the PRAS40 and other Akt/mTOR pathway proteins. Future studies will reveal the mechanistic details how cellular and secreted gremlin-1 regulates these pathways.
We and others have previously linked gremlin-1 expression to EMT processes. 16, 40, 41 In cancer cells, markers of EMT often suggest more advanced disease, invasive capacity and chemoresistance. 21, 42 We found that the transcription factor slug, a master regulator of EMT, was upregulated in mesothelioma cells concurrently with gremlin-1. Silencing of gremlin-1 expression led to reduced slug mRNA and protein levels. Further, mesenchymal markers of EMT, vimentin, a-smooth muscle actin, fibronectin and N-cadherin were downregulated in gremlin-1-silenced cells, whereas epithelial marker E-cadherin was upregulated. These results are in agreement with previous studies linking the expression of EMT-related transcription factors to mesothelioma 43, 44 and provide evidence that gremlin functions as a regulator of these transitional processes. EMT and slug expression have also been suggested to be involved in regulating cancer stemness as well as chemoresistance. 18, 20, 42 In agreement, we observed that high gremlin-1 and slug expressions in mesothelioma cells were associated with reduced sensitivity to paclitaxel-mediated cell death. Combined treatment with paclitaxel and gremlin-1 siRNA led to efficient cell death in vitro. Similar results were obtained with pemetrexed, which is a relatively new cancer drug used in the treatment of mesothelioma in combination with platinum compounds. 45 This indicates that blocking gremlin-1 function may be beneficial in mesothelioma especially when combined with chemotherapy.
Mesothelioma is an aggressive tumor with limited treatment options. Further, an increase is expected in the incidence of mesothelioma, 3, 4 which sets an urgent need for new drug target molecules. Although the number of patient tissues analyzed in our study was relatively small (n ¼ 6), the pathological expression of gremlin-1 was a clear concept. It is also reinforced by other studies suggesting a role for gremlin-1 in cancer cell proliferation. 12, 13, 33, 34 Gremlin-1 has also BMP-independent angiogenic functions, 46 which may well contribute to tumor progression. Blocking gremlin-1 function in mesothelioma might offer means to fight the chemoresistance of this tumor. Figure 9 . A model for the functions of gremlin-1 and fibrillin-2 in mesothelioma. Gremlin-1 induces proliferation and epithelial-tomesenchymal transition (EMT) in mesothelioma cells. EMT is mediated by induction of the transcription factor slug and leads to chemoresistance and acquisition of invasive properties. Gremlin-1 is targeted to the tumor microenvironment through binding to fibrillin-2 microfibrils.
MATERIALS AND METHODS Antibodies
Antibodies used in the study are summarized in Table 2 .
Patients and tissues specimen
A statement for the use of human tissue and pleural effusion materials was received from the Ethics Committee of the Helsinki University Hospital, Helsinki, Finland (number 308/13/0301/2010). All patients gave informed consent to participate in the study. Tissue biopsies and pleural effusion samples were obtained from patients undergoing diagnostic procedures and had a clinical and/or radiological suspicion of malignant mesothelioma. All patients included in the study (n ¼ 7) were later diagnosed to have mesothelioma (Table 3) . Control pleural samples were obtained from two male smokers who were operated for pneumothorax.
Cell culture and transient transfection
Immortalized normal mesothelial cells (Met5A), 47 and mesothelioma cell lines (211H, H28, H2452 and H2052) were from ATCC. Primary mesothelioma cells (named JP cells) were acquired from pleural effusion samples from patients suffering from malignant mesothelioma. Cells were centrifuged, washed and seeded on plastic culture dishes in RPMI-1640 medium (Sigma, St Louis, MO, USA) supplemented with 10% fetal bovine serum (Sigma) and antibiotics. The medium was changed every 3-4 days. Cells were passaged 2-3 times before immunofluorescence analysis of mesothelioma marker proteins was performed. Cells were also cultured for 6-7 days for RNA isolation and gene expression analyses. For further experiments JP5 cells were cultured and used between passages 3-7. Transfection of cells was carried out using siRNAs for gremlin, fibrillin-1 or a negative control (Life Technologies, Paisley, UK) as described. 48 The BMP reporter construct (Bre2-luc, kindly provided by Dr Peter ten Dijke, Leiden University Medical Center, the Netherlands) was transfected into H2052 cells to assess BMP-dependent signaling activity as described. 49 Expression constructs and stable transfection C-terminal gremlin-1 construct was generated by Gateway-cloning, the gremlin-1 construct from the Human Orfeome Collection (Thermo Scientific, FL, USA) to a pTO-SHc-GW-FRT plasmid with c-terminal Streptag III and human influenza hemagglutinin (HA)-tag.
14 Flip-In human embryonic kidney (HEK) 293 cells (Life Technologies) were grown as recommended. Stable transfection of cells was carried out as described. 50 After 2 weeks of culture, hygromycin B-resistant clones were tested for tetracycline (Sigma)-inducible gremlin-1 expression (see Figure 1b) .
Affinity purification
Transfected Flip-In HEK293 cells were stimulated with tetracycline (25 ng/ ml) to induce gremlin-1 expression. After a 24-h stimulation, cells were lysed in HNN-lysis buffer (50 mM HEPES pH 8, 150 mM NaCl, 50 mM NaF, 1 mM PMSF, 1.5 mM Na-vanadate, 0.5% NP-40 and protease inhibitors (Sigma)) followed by double affinity purification as described. 50 Briefly, cell lysates were passed through Strep-Tactin columns (IBA GmbH) followed by elution of bound proteins with 2.5 mM biotin. Next, the eluate was immunoprecipitated using anti-HA agarose (Sigma). Proteins were finally eluted using 0.2 M glycine and neutralized.
Protein digestion
The total protein amount from the elution fractions was precipitated using trichloroacetic acid (TCA). First, TCA was added to the elution fractions to final concentration of 25% followed by incubation for 30 min on ice. The precipitates were centrifuged, washed once with ice cold 0.1 M HCl in acetone and once with acetone. The pellets were then allowed to dry. For trypsin digestion the precipitated proteins were dissolved in 50 mM ammonium bicarbonate, pH 8.9, containing 0.1% Rapigest detergent (Waters, Milford, MA, USA). Proteins were reduced using DTT for 30 min at 60 1C followed by alkylation using iodoacetamide for 30 min at room temperature in dark. Proteins were digested with trypsin (Promega, Madison, WI, USA) for 18 h at 37 1C, and then the Rapigest detergent was hydrolyzed with HCl for 45 min at 37 1C. Peptides were purified with PepClean C18 Spin Columns (Thermo Fisher, Rockford, IL, USA) according to the manufacturer's protocol. Finally, the purified peptides were dissolved in 0.1% formic acid for MS analysis. 
LC-MS/MS analysis
Mass spectrometric analysis was performed using nanoAcquity UPLCliquid chromatography system on-line with a Waters Synapt G2 mass spectrometer (Waters S.A.S., Saint-Quentin, France). Waters nanoAcquity UPLC Trap Column (Symmetry C18, 180 mm Â 20 mm, 5 mm) was used as trapping and Waters nanoAcquity UPLC Column (BEH130 C18, 75 mm Â 150 mm, 1.7 mm) as analytical column. Four microliters of sample was injected and run using 90 min gradient from 3 to 40% mobile phase B (0.1% formic acid in acetonitrile). 0.1% formic acid in water was used as mobile phase A. Data were collected with data dependent acquisition manner collecting eight fragmentation spectra simultaneously. Switch limit from MS to MS/ MS was set to peak intensity of 200. Fragmentation data for detected peaks were collected for 5 s and then excluded from fragmentation for 120 s. Scan time for both MS and MS/MS was one second. No lockmass correction was used.
The raw data were processed with Mascot Distiller software (version 2.3.1.0, Matrix Science, London, UK), and database search was performed using Mascot search engine (version 2.2.04) against Swiss-Prot human database (dated 16.6.2010). MudPIT scoring and Ion score cutoff limit of 20 were used to identify peptides. Require bold red-specification was used to limit the results to those proteins that have at least one unique peptide. Carbamidomethylated cysteine was set as fixed modification and oxidation of methionine as variable modification. Peptide mass tolerance for search was 0.2 Da and 0.1 Da for fragment ion search. A maximum of two missed trypsin cleavages was allowed. The Mascot Distiller processed data were also searched using GPM X!Tandem search engine 51 using same parameters.
Expression and purification of recombinant gremlin-1
The expression construct pGremlin-1_V5/HIS in pEF-IRES-P contains cDNA encoding human gremlin-1 with C-terminal tags (V5 and 6HIS). H2052 and H28 cells were transiently transfected with this construct or the expression vector using Fugene HD transfection reagent (Promega). CHO cells were stably transfected, and gremlin-containing cell culture supernatants were produced as described. 52 The media was then dialyzed against 50 mM sodium phosphate buffer, pH 7.2 and 1 M NaCl (buffer A) and loaded on a 1-ml HiTrap column (GE Health Care, Waukesha, WI, USA) previously charged with CoCl 2 and equilibrated with buffer A. The loaded column was washed with 40 column volumes of buffer A and subjected to a fast protein liquid chromatography (GEHC) gradient run starting with buffer A containing 0-100% buffer B (buffer A with 250 mM imidazole). Fractions were analyzed using SDS-PAGE for their purity and molecular mass, and imidazole in these fractions was removed by dialysis against buffer A. For further concentration and purification, gremlin-1-containing fractions were dialyzed against TBS and subjected to affinity chromatography using a 1-ml HiTrap heparin column (GEHC). Bound gremlin-1 was eluted in a 0-1 M NaCl gradient.
Surface plasmon resonance
Binding analyses were performed using a BIAcore2000 (GEHC). 2000 Rus of gremlin-1 were covalently coupled to carboxymethyldextran hydrogel 500 M sensor chips (XanTec, Dü sseldorf, Germany) using the amine coupling kit following the manufacturer's instructions (GEHC). Binding assays with N-terminal fibrillin-1 (rF11) and -2 peptides (rF86) as analytes were performed as previously described. 9 Kinetic constants were calculated by nonlinear fitting of association and dissociation curves (BIAevaluation 4.1 software).
Immunohistochemical staining and proximity ligation assay
Immunohistochemical staining of tumor tissues and proximity ligation assay were performed as described. 24 Images were captured with Nikon DS-Fi1 or with Axio Imager with ApoTome (Zeiss, Gö ttingen, Germany) or with using Axio Vison 4.8 software (Zeiss).
SDS-PAGE and immunoblotting
Cells were lysed in RIPA lysis buffer (50 mM Tris-HCl, pH 7.4, 150 mM NaCl, 1 mM EDTA, 1% NP-40, 0.2% sodium deoxycholate) containing protease inhibitors (Roche, Mannheim, Germany) for 15 min on ice. Protein concentrations were measured using a BCA protein assay Kit (Pierce, Rockfors, IL, USA). SDS-PAGE and immunoblotting were performed as described. 53 RNA isolation and gene expression analyses Isolation of total cellular RNA, reverse transcription and quantitative realtime PCR were carried out as described. 53 The relative gene expression differences were calculated with the comparative delta delta cycle threshold (DDCT) method, and the results have been expressed as mRNA expression levels normalized to the levels of a gene with a constant expression (TATA-binding protein).
Immunofluorescence analyses and microscopy Cells were grown on glass coverslips for the indicated times and fixed with 4% paraformaldehyde in PBS at room temperature for 10 min or with ice cold methanol at À 20 1C for 20 min. Immunofluorescence staining was carried out as described. 53 Images were captured with a Axioplan 2 epifluorescence microscope (Zeiss) and AxioCam HRm 14-bit grayscale CCD camera Axiovision 4.6 software (Zeiss).
Human phospho-kinase array Control and gremlin-1 siRNA-treated cells were lysed, and alterations in phospho-kinase levels were analyzed using a Proteome profiler array (ARY003b, R&D Systems, Gaitherburg, MD, USA) according to the manufacturer's instructions. Quantity One version 4.6 (BioRad, Hercules, CA, USA) was used for quantification. The kinase array was performed twice, and the results are expressed as average of the two experiments.
Measurements of cell viability and apoptosis
Cell proliferation/viability was assessed using MTT assay (R&D Systems). Briefly, cells were seeded on 96-well plates (10 000/well) and were treated the next day with different concentrations of paclitaxel (Hospira, Lake Forest, IL, USA). The metabolic activity of cells was measured after 48 h according to the manufacturer's instructions. Apoptosis was assayed using a TUNEL technology using In Situ cell death detection kit (Roche). Cells were seeded on glass coverslips, cultured overnight and transfected with siRNAs. Cells were then fixed and stained, according to the manufacturer's instructions, 3 days after transfection.
Statistical analyses
Data were analyzed using PASW Statistics 18 program for Windows (SPSS, Chicago, IL, USA). Statistical difference between two independent groups was evaluated using nonparametric Mann-Whitney U-test. Statistical difference between more than two independent groups was evaluated using nonparametric Kruskal-Wallis test. A P-value of o0.05 was considered statistically significant.
